BR0114031A - Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina - Google Patents

Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina

Info

Publication number
BR0114031A
BR0114031A BR0114031-0A BR0114031A BR0114031A BR 0114031 A BR0114031 A BR 0114031A BR 0114031 A BR0114031 A BR 0114031A BR 0114031 A BR0114031 A BR 0114031A
Authority
BR
Brazil
Prior art keywords
olanzapine
hydrates
preparation
conversion
crystalline forms
Prior art date
Application number
BR0114031-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Buchi Reddy Reguri
Ramesh Chakka
Robert Koprowaski
Original Assignee
Reddy S Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy S Lab Ltd filed Critical Reddy S Lab Ltd
Publication of BR0114031A publication Critical patent/BR0114031A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0114031-0A 2000-08-31 2001-03-07 Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina BR0114031A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN711CH2000 2000-08-31
IN709CH2000 2000-08-31
PCT/US2001/007258 WO2002018390A1 (fr) 2000-08-31 2001-03-07 Procede de preparation d'hydrates d'olanzapine et de conversion de ceux-ci en formes cristallines d'olanzapine

Publications (1)

Publication Number Publication Date
BR0114031A true BR0114031A (pt) 2003-09-09

Family

ID=26324874

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114031-0A BR0114031A (pt) 2000-08-31 2001-03-07 Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina

Country Status (12)

Country Link
EP (1) EP1313742A1 (fr)
JP (1) JP2004507548A (fr)
AU (1) AU2001243475A1 (fr)
BR (1) BR0114031A (fr)
CA (1) CA2420987A1 (fr)
CZ (1) CZ2003566A3 (fr)
HU (1) HUP0300875A3 (fr)
IL (1) IL154688A0 (fr)
NO (1) NO20030926L (fr)
RU (1) RU2003108745A (fr)
SK (1) SK2502003A3 (fr)
WO (1) WO2002018390A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002340328A1 (en) * 2001-10-29 2003-05-12 Janet I. Cord Olanzapine dihydrate-ii a process for its preparation and use thereof
WO2003091260A1 (fr) * 2002-04-23 2003-11-06 Dr. Reddy's Laboratories Limited Nouvelle forme vi polymorphe cristalline d'olanzapine et procede de preparation
AU2002251329A1 (en) * 2002-04-25 2003-11-10 Generics (Uk) Limited Novel crystalline forms of celecoxib and other compounds
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
ATE500258T1 (de) 2002-05-31 2011-03-15 Sandoz Ag Verfahren zur herstellung von olanzapin form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
EP1575962A1 (fr) 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Nouvelles formes cristallines d'olanzapine, procedes pour les preparer et procede pour preparer des formes cristallines d'olanzapine connues
EP1611139B1 (fr) 2003-12-22 2008-06-04 Teva Pharmaceutical Industries Ltd. Methodes de preparation de l'olanzapine
AR047460A1 (es) * 2004-01-27 2006-01-18 Synthon Bv Proceso para la fabricacion de acetato de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (acetato de olanzapina)
WO2005070938A1 (fr) 2004-01-27 2005-08-04 Synthon B.V. Sels stables d'olanzapine
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2005107375A2 (fr) * 2004-05-06 2005-11-17 Matrix Laboratories Ltd Procede pour la preparation de forme i d'olanzapine
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
CA2576862C (fr) 2004-07-14 2012-09-11 Jubilant Organosys Limited Procede permettant de produire une forme pure de 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benzodiazepine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006025065A1 (fr) * 2004-08-31 2006-03-09 Lee Pharma Private Limited Procédé pour la préparation de chlorhydrate d'olanzapine anhydre de forme 1
ES2303462B1 (es) * 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
US7932249B2 (en) * 2005-01-05 2011-04-26 Eli Lilly And Company Olanzapine pamoate dihydrate
WO2006102176A2 (fr) * 2005-03-21 2006-09-28 Dr. Reddy's Laboratories Ltd. Procede de preparation d'une forme cristalline i d'olanzapine
HUP0501046A2 (en) * 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
CA2687143A1 (fr) * 2007-05-15 2008-11-20 Generics [Uk] Limited Procede de purification d'olanzapine
EP2292624A1 (fr) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Processus de purification d'olanzapine
CN102093386B (zh) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 一种制备奥兰扎平晶型ⅱ的方法
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法
FI3466934T3 (fi) 2016-05-31 2024-04-23 Taiho Pharmaceutical Co Ltd Sulfonamidiyhdisteitä tai niiden suola ribonukleotidireduktaasin inhibiittoreina syövän hoitamiseksi

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
ID21924A (id) * 1996-09-23 1999-08-12 Lilly Co Eli Olanzapin dihidrat d
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine

Also Published As

Publication number Publication date
WO2002018390A1 (fr) 2002-03-07
CZ2003566A3 (cs) 2004-01-14
RU2003108745A (ru) 2005-01-10
SK2502003A3 (en) 2004-03-02
EP1313742A1 (fr) 2003-05-28
HUP0300875A3 (en) 2005-09-28
CA2420987A1 (fr) 2002-03-07
AU2001243475A1 (en) 2002-03-13
HUP0300875A2 (hu) 2003-12-29
JP2004507548A (ja) 2004-03-11
IL154688A0 (en) 2003-09-17
NO20030926D0 (no) 2003-02-27
NO20030926L (no) 2003-04-24

Similar Documents

Publication Publication Date Title
BR0114031A (pt) Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
CO5040084A1 (es) Forma polimorfa del hidrogenosulfato de clopidogrel
IS7319A (is) Fjölgervingar klópídógrelvetnissúlfats
DE60228926D1 (de) Sekundärbatterie mit nichtwässrigen Elektrolyten und Verfahren zu ihrer Herstellung
CO4900057A1 (es) Dihidrato d de olanzapina
HUP9802824A3 (en) Novel crystal form of the 2-methyl-4-(4-methyl-1-piprezinyl)-10h-thieno[2,3-b][1,5]benzodiazepine and process for its preparation
WO2005090359A3 (fr) Synthese de 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine, et sels dudit compose
HK1053327A1 (zh) 培養間葉幹細胞的方法
MX2008013724A (es) Proceso para la preparacion de formas polimorficas de hidrogeno sulfato clopidrogel.
BR0305100A (pt) Processo para a preparação de olanzapina
ID23578A (id) Badan berwarna yang dibakar sampai berwarna merah coklat, proses untuk pembuatannya dan penggunaannya
DK1620439T3 (da) Hidtil ukendte polymorfer af olanzapinhydrochlorid
IL192825A0 (en) A PROCESS FOR THE PREPARATION OF POLYMORPH FORM I OF (S)-(+)-METHYL-ßé?- (2-CHLOROPHENYL)-6,7-DYHIDRO-THIENO-[3,2-C]PYRIDINE-5(4H)-ACETATE HYDROGEN SULFATE
WO2003037903A8 (fr) Dihydrate-ii d'olanzapine: son procede de preparation et son utilisation
HK1045685B (zh) 製備一硝基甲苯的連續等温方法
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
ID25705A (id) Proses pembuatan 8-siklopentil-6-etil-3-[tersubstitusi]-5,8-dihidro-4h-1 3a 8-pentaaza-as-indasena dan senyawa-senyawa antaranya yang berguna
PT1392698E (pt) Processo para a preparacao de 6-aril-4h-s-triazolo [3,4-c]-tieno[2,3-e]-1,4-diazepinas
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
HU0700809D0 (en) Racemisation process for producing methyl (r,s)-(+)-alpha-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridin-5(4h)-acetate hydrogene sulfate intermediate
PL361052A1 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine
GB0023989D0 (en) Database query method for low-bandwidth envirments
UA86772C2 (en) Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate
AU2002249279A1 (en) Method for the production of 6-aryl-4h-s-triazolo(3,4-c)-thieno(2,3-e)-1,4-diazepines

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS.